Sixth Street Partners Management Company »

Biosante Pharmaceuticals shares owned by Sixth Street Partners Management Company

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Sixth Street Partners Management Company from 13F filings

Historical chart of Sixth Street Partners Management Company investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Sixth Street Partners Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Sixth Street Partners Management Company

Quarter filed Position value Share count Share price at filing
2026-06-30 $21M 253k 82.78

More positions owned by Sixth Street Partners Management Company

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Schwab Strategic Tr Fundamental Us L (FNDX)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
UnitedHealth (UNH)
Tesla Motors (TSLA)
Micron Technology (MU)
Schwab Strategic Tr Fundamental Intl (FNDF)
Eli Lilly & Co. (LLY)
Home Depot (HD)

View all positions for Sixth Street Partners Management Company

Top funds holding Biosante Pharmaceuticals

BlackRock
Soleus Capital Management
Vanguard Capital Management
State Street Corporation
Tang Capital Management
Dimensional Fund Advisors
American Century Companies
Arrowstreet Capital, Limited Partnership
Global Alpha Capital Management
Geode Capital Management
Millennium Management
Nuveen
Vanguard Portfolio Management
Ranger Investment Management
Deutsche Bank Aktiengesellschaft

View all funds holding Biosante Pharmaceuticals